Study of BMS-936558 (Nivolumab) Compared to Docetaxel in Previously Treated Metastatic Non-squamous NSCLC
Clinical trial NCT01673867 · COMPLETED
Trial details
- NCT number
- NCT01673867
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-02
- Primary completion
- 2015-02-05
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.